Our suite of preeclampsia, prenatal, breast and gynecological cancer, and other testing has been developed in collaboration with clinical leaders in a variety of women’s health specialties to provide accurate, actionable results.
New tests launched in October - Insights
In October 2022, Mayo Clinic Laboratories announced thirty new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
New tests launched in March - Insights
In March 2022, Mayo Clinic Laboratories announced eighteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Improving diagnosis and treatment of Helicobacter pylori - Insights
Mayo Clinic Laboratories now offers a noninvasive approach for the molecular detection of H. pylori, with results that include prediction of clarithromycin resistance delivered within 24 hours.
Communiqué Archives - Page 2 of 4 - Insights
Skip to Content MayoACCESS MayoLINK...
Testing Archives - Page 2 of 26 - Insights
Skip to Content MayoACCESS MayoLINK...
Testing Archives - Page 3 of 26 - Insights
Skip to Content MayoACCESS MayoLINK...
Testing Archives - Page 4 of 26 - Insights
Skip to Content MayoACCESS MayoLINK...
A Test in Focus Archives - Insights
Skip to Content MayoACCESS MayoLINK...
Mitochondrial Disease [Test in Focus] - Insights
Linda Hasadsri, M.D., Ph.D., explains how Mayo Clinic Laboratories’ inclusive approach to mitochondrial disease testing expedites diagnosis. Using innovative methodologies like custom reagents and droplet digital PCR enables precision...